Literature DB >> 8395324

The equine herpesviruses.

E N Ostlund1.   

Abstract

Two viruses, EHV-1 and EHV-4, are now known to be responsible for disease conditions formerly considered caused by "equine rhinopneumonitis virus." Although these viruses share several laboratory and clinical features, they differ in epidemiology and pathogenic potential. EHV-4 is primarily associated with clinical respiratory disease, whereas EHV-1 is more frequently isolated from aborted fetuses, sickly foals, and neurologic cases. Both viruses frequently establish latent infections, but the relevance of latency to clinical disease is unclear. Diagnosis based on identification of the pathogen is generally superior to serologic methods. Vaccines containing each virus are available, and vaccination in concert with careful management limits the number of clinical cases. Immunity following vaccination or disease is not absolute, however, and improved disease prophylaxis awaits a better understanding of protective immune responses.

Entities:  

Mesh:

Year:  1993        PMID: 8395324     DOI: 10.1016/s0749-0739(17)30396-6

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  9 in total

1.  The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.

Authors:  Tobias Bergmann; Carrie Moore; John Sidney; Donald Miller; Rebecca Tallmadge; Rebecca M Harman; Carla Oseroff; Amanda Wriston; Jeffrey Shabanowitz; Donald F Hunt; Nikolaus Osterrieder; Bjoern Peters; Douglas F Antczak; Alessandro Sette
Journal:  Immunogenetics       Date:  2015-09-23       Impact factor: 2.846

2.  Equine herpesvirus myeloencephalopathy in a 14-year-old quarter horse stallion.

Authors:  T F Olsen
Journal:  Can Vet J       Date:  2001-03       Impact factor: 1.008

3.  Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo.

Authors:  G A Sutton; L Viel; P S Carman; B L Boag
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

4.  Successful control of winter pyrexias caused by equine herpesvirus type 1 in Japanese training centers by achieving high vaccination coverage.

Authors:  Hiroshi Bannai; Naomi Mae; Hirotaka Ode; Manabu Nemoto; Koji Tsujimura; Takashi Yamanaka; Takashi Kondo; Tomio Matsumura
Journal:  Clin Vaccine Immunol       Date:  2014-05-28

5.  Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.

Authors:  G Allen; M Yeargan; L R Costa; R Cross
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Low-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus I in horses.

Authors:  Wendy Pearson; Semir Omar; Andrew F Clarke
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

7.  Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.

Authors:  B Garré; K Shebany; A Gryspeerdt; K Baert; K van der Meulen; H Nauwynck; P Deprez; P De Backer; S Croubels
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

Review 8.  EHV-1: A Constant Threat to the Horse Industry.

Authors:  Fatai S Oladunni; David W Horohov; Thomas M Chambers
Journal:  Front Microbiol       Date:  2019-12-03       Impact factor: 5.640

9.  Investigation of an EHV-1 Outbreak in the United States Caused by a New H752 Genotype.

Authors:  Nicola Pusterla; Samantha Barnum; Julia Miller; Sarah Varnell; Barbara Dallap-Schaer; Helen Aceto; Aliza Simeone
Journal:  Pathogens       Date:  2021-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.